Although there is limited evidence regarding the exact role of UBA52 in PCa, some studies have reported its upregulation in pancreatic cancer and its association with the promotion and progression of multiple myeloma and gastric cancer [16,59,60]. Here, UBA52 is linked to plasma cell myeloma.